Skip to main content
Rethinking ELN and LIMS – anicomply as the more flexible path to controlled lab digitalization
News Pinned

Rethinking ELN and LIMS: Why anicomply Is the More Flexible Path to Controlled Lab Digitalization

Laboratory managers, IT business partners and technical management know the problem: the SOP is stored in Word, execution happens on paper or in Excel, and every change to a method means weeks of effort — ticketing, vendor coordination and revalidation. Traditional ELN and LIMS systems often adapt processes only slowly and rigidly. What is missing is a system that can directly take over existing Word documents and immediately turn them into executable, controlled workflows.

This is exactly what anicomply does.

Read article: Rethinking ELN and LIMS: Why anicomply Is the More Flexible Path to Controlled Lab Digitalization
The First FDA Warning Letter Referencing AI: Why the Failure Was Not the Technology, but the Lack of Control
News Pinned

The First FDA Warning Letter Referencing AI: Why the Failure Was Not the Technology, but the Lack of Control

The first FDA Warning Letter explicitly referencing the use of Artificial Intelligence is making waves across the industry. But a closer look reveals: the failure was not the technology itself, but the lack of control around it. Missing validation, insufficient documentation, and poor process integration — the actual weaknesses are well-known GMP issues.

Warning Letter analyzed in detail: The First FDA Warning Letter Referencing AI: Why the Failure Was Not the Technology, but the Lack of Control
The Path to the Agile Lab: Why Traditional EBR Systems Are Slowing Down the Pharmaceutical Industry—and How to Break Free
News Pinned

The Path to the Agile Lab: Why Traditional EBR Systems Are Slowing Down the Pharmaceutical Industry—and How to Break Free

Why do recipe changes in your production still take months? While the market demands agility, rigid EBR systems slow down innovation. Discover how to break free from the "golden cage"—from paper chaos through digital bottlenecks to true production agility in hours instead of quarters.

A way out of the dilemma?: The Path to the Agile Lab: Why Traditional EBR Systems Are Slowing Down the Pharmaceutical Industry—and How to Break Free
anic auf der PHARMA MES Europe 2026 – Stand 45, 1. und 2. Oktober 2026, Maritim proArte Hotel Berlin
News

anicomply at PHARMA MES Europe 2026

A short demo. Clear answers for your batch process.

At PHARMA MES Europe 2026, we will show you how anicomply digitally maps regulated process steps, guides users through their tasks and documents process data in a traceable way.

A product demo does not have to be long to answer the decisive questions. The presentation focuses on the essentials. In a short time, you gain a clear insight into the digital flow of a batch process and see directly where anicomply can support your existing processes.

Our review: the key takeaways from PHARMA MES Europe 2026 in Berlin.: anicomply at PHARMA MES Europe 2026
Andreas Nicklas, CEO anic GmbH, im Interview mit der phpro über pragmatische Digitalisierung in der Pharmaproduktion
News

We're featured in phpro – Interview with Andreas Nicklas

Yes — we're featured in phpro. And most importantly: we're not only addressing those who are already producing in a fully digital environment. In practice, a large number of pharmaceutical manufacturers — around 60–70% — are still working with paper-based batch documentation. That is exactly why the interview with Andreas Nicklas is worth reading: it explores how to approach the move toward digitalization in a pragmatic way — and why change must never become a bottleneck in the process.

Read article: Interview with Andreas Nicklas in phpro – From Bottleneck to Change Routine

Page 1 of 4